Publication: Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012
| cris.lastimport.scopus | 2025-05-15T22:06:21Z | |
| cris.virtual.department | Oncology-NTUH | en_US |
| cris.virtual.orcid | #PLACEHOLDER_PARENT_METADATA_VALUE# | |
| cris.virtualsource.department | 07cf43be-4cba-4dc0-b182-b5937eec7f31 | |
| cris.virtualsource.orcid | 07cf43be-4cba-4dc0-b182-b5937eec7f31 | |
| dc.contributor.author | Tahara M. | en_US |
| dc.contributor.author | Muro K. | en_US |
| dc.contributor.author | Hasegawa Y. | en_US |
| dc.contributor.author | Chung H.C. | en_US |
| dc.contributor.author | CHIA-CHI LIN | en_US |
| dc.contributor.author | Keam B. | en_US |
| dc.contributor.author | Takahashi K. | en_US |
| dc.contributor.author | Cheng J.D. | en_US |
| dc.contributor.author | Bang Y.-J. | en_US |
| dc.date.accessioned | 2022-09-15T01:09:23Z | |
| dc.date.available | 2022-09-15T01:09:23Z | |
| dc.date.issued | 2018 | |
| dc.identifier.doi | 10.1111/cas.13480 | |
| dc.identifier.issn | 1347-9032 | |
| dc.identifier.pmid | 29284202 | |
| dc.identifier.scopus | 2-s2.0-85041698363 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041698363&doi=10.1111%2fcas.13480&partnerID=40&md5=0039e511128bc15e649b880eb27de8f5 | |
| dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/620272 | |
| dc.publisher | Blackwell Publishing Ltd | |
| dc.relation.ispartof | Cancer Science | |
| dc.relation.journalissue | 3 | |
| dc.relation.journalvolume | 109 | |
| dc.relation.pages | 771-776 | |
| dc.title | Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012 | en_US |
| dc.type | journal article | en |
| dspace.entity.type | Publication |